John Egan, a partner in and co-chair of the firm’s Technology Companies + Life Sciences Group, focuses on corporate securities, venture capital, growth equity and technology enterprises. Mr. Egan's practice involves early and late-stage venture financings, growth equity and leveraged recapitalizations, IPOs, mergers and acquisitions, joint ventures, strategic licensing and the general representation of public and private emerging growth companies. Mr. Egan works with clients in industries ranging from enterprise software, networking, security and business services to communications, media and life sciences. He also represents numerous venture capitalists, private equity investors and investment banks and has extensive experience in intellectual property and licensing issues. Mr. Egan is a key contributor to the Goodwin's Founders Workbench, an online resource for start-ups, emerging companies and the entrepreneurial community. He rejoined Goodwin in 2005.
Mr. Egan’s practice involves early and late-stage venture financings, growth equity and leveraged recapitalizations, IPOs, mergers and acquisitions, joint ventures, strategic licensing and the general representation of public and private emerging growth companies in industries ranging from enterprise software, networking, security and business services to communications, media and life sciences. He also represents numerous venture capitalists, private equity investors and investment banks and has extensive experience in intellectual property and licensing issues.
Prior to rejoining Goodwin, Mr. Egan was a partner at McDermott Will & Emery in Boston, where he was a member of that firm's Corporate Department and global head of its Private Equity/Emerging Companies Group.
Mr. Egan has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business, U.S. News-Best Lawyers and The Legal 500 U.S.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。